Osi Systems IncOSIS

OSI Systems reported record third-quarter revenues of $453 million, driven by a 25% jump in the Security division’s year-over-year sales, with Mexico proving the standout geography. The headline hides a twist: the company’s own SEC filing admits the prior-year comparator was juiced by “significant Mexico revenues” in fiscal 2025, so the headline growth deserves an asterisk the size of a sombrero. (source: Press Release of OSI Systems, Inc. dated May 4, 2026, https://www.sec.gov/Archives/edgar/data/1039065/000110465926054857/tm2613470d1_ex99-1.htm)

Behind the glossy healthcare banner on the company’s site lies a sprawling three-business model: Security, Healthcare, and the quietly acquisitive Printed Circuit Board unit. The healthcare arm sells patient monitors and imaging systems, while Security cranks out screening portals and smart cabinets, but the real action is in the deferred-revenue column. OSI’s service contracts let it bank cash before the work is done, swelling deferred revenue by $12.1 million in the latest quarter even as contract assets fell by $67.9 million-a sign that invoices are playing catch-up with the cash register. (source: SEC EDGAR 10-Q ending 31 March 2026, https://www.sec.gov/Archives/edgar/data/1039065/000110465926055014/osis-20260331x10q.htm)

The balance sheet shows $345.2 million in cash and equivalents alongside $2.55 billion of assets and $1.66 billion of liabilities, leaving shareholders with $894.3 million of equity. Net income clocked in at $40.2 million for the quarter, supported by $93.8 million of operating cash flow and a modest $21.3 million in capex. Earnings per share reached $2.33 on 17.3 million diluted shares, while inventory swelled by $29.6 million to $435.3 million-enough to make any logistics manager sweat. Warranty accruals ticked up by $2.4 million, a rounding error next to the warehouse headache. (source: SEC EDGAR 10-Q ending 31 March 2026, https://www.sec.gov/Archives/edgar/data/1039065/000110465926055014/osis-20260331x10q.htm)

OSI’s website devotes a page to “Innovation and Quality,” complete with a photo of cheerful-looking staff and a promise to safeguard intellectual property via its Political Action Committee. The page links to legally mandated disclosures of recipients and amounts, but the gap between the polished story and the filing reality is visible in the numbers: R&D spend of $19.5 million sits against a $40.2 million net profit, while inventory growth outpaces operating cash flow. The PAC’s transparency is admirable, yet the bigger question is whether the company can turn its $435 million inventory mountain into revenue before next quarter’s rent becomes due. (source: Innovation and Quality | OSI Systems, https://www.osi-systems.com/about-osi/innovation-quality/)

A stroll through the SEC EDGAR filings shows a recent flurry of Form 4 disclosures dated 21 July 2026, all labelled OSIS 4-presumably executives tidying up their holdings. With no valuation commentary, trading volumes, or index moves supplied in the evidence, the only tradeable signal is the balance sheet itself: cash good, inventory awkward, and deferred revenue growing faster than the warehouse can organise it. (source: OSIS 4 (2026-07-21), SEC EDGAR Form 4 filings, https://www.sec.gov/Archives/edgar/data/1039065/000179592426000005/xslF345X06/form4-07212026_040709.xml)

The company’s healthcare business sells imaging systems and patient monitors, but the latest 10-Q does not break out segment-level profitability beyond the top-line growth in Security. The website’s healthcare banner and product image are decorative; the filing evidence is what counts, and it shows a diversified revenue engine with a single-digit R&D weight relative to cash generation. Whether that engine can digest $435 million of inventory without indigestion is the open question. (source: Healthcare | OSI Systems, https://www.osi-systems.com/our-businesses/healthcare/)